Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Appointment of Joint Broker

1st Sep 2025 07:00

RNS Number : 2908X
Eco Animal Health Group PLC
01 September 2025
 

1 September 2025

ECO Animal Health Group plc (''ECO" or the "Company")

Appointment of Joint Broker

 

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces the appointment of Panmure Liberum Limited ("Panmure Liberum") as Joint Broker to the Company with immediate effect. Singer Capital Markets will remain as the Company's Nominated Adviser and Joint Broker.

 

-Ends-

 

Contacts

 

ECO Animal Health Group plc

David Hallas (Chief Executive Officer)

Christopher Wilks (Chief Financial Officer)

 

020 8447 8899

ICR Healthcare (Financial PR)

Mary-Jane Elliott

Jessica Hodgson

 

020 3709 5700

 

Singer Capital Markets (Nominated Adviser & Joint Broker)

Philip Davies

Sam Butcher

 

020 7496 3000

Panmure Liberum (Joint Broker)

Emma Earl

Will Goode

Mark Rogers

Rupert Dearden

 

020 3100 2000 

 

 

 

Equity Development

Hannah Crowe

Matt Evans

 

020 7065 2692

 

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

 

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

 

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

 

Click here for more information: https://ecoanimalhealth.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPZZGZRZLKGKZM

Related Shares:

Eco Animal
FTSE 100 Latest
Value9,116.69
Change-79.65